The STRITUVAD (In Silico TRIals for TUberculosis VAccine Development) project has been completed. It has been a great honour for Archivel to be part of this project co-funded by the EU and the Department of BioTechnology of the Government of India.
The ultimate goal of the project is to validate an in Silico Model through data obtained by RUTI clinical trial in India. Please, find attached the final brochure newsletter.
#RUTI #Archivelfarma #vaccine #tuberculosis #NCT04919239 #India
